您的位置: 专家智库 > >

国家自然科学基金(30371396)

作品数:5 被引量:8H指数:2
相关作者:郑启昌尚丹宋自芳熊俊舒晓刚更多>>
相关机构:华中科技大学更多>>
发文基金:国家自然科学基金更多>>
相关领域:医药卫生更多>>

文献类型

  • 5篇中文期刊文章

领域

  • 5篇医药卫生

主题

  • 2篇血管
  • 2篇血管平滑肌
  • 2篇血管平滑肌细...
  • 2篇移植静脉
  • 2篇移植静脉内膜...
  • 2篇增生
  • 2篇平滑肌
  • 2篇平滑肌细胞
  • 2篇自体
  • 2篇自体静脉
  • 2篇自体静脉移植
  • 2篇自体移植
  • 2篇自体移植静脉
  • 2篇自体移植静脉...
  • 2篇细胞
  • 2篇内膜
  • 2篇内膜增生
  • 2篇静脉
  • 2篇静脉内膜
  • 2篇静脉内膜增生

机构

  • 3篇华中科技大学

作者

  • 3篇宋自芳
  • 3篇尚丹
  • 3篇郑启昌
  • 2篇熊俊
  • 2篇舒晓刚
  • 1篇管思明
  • 1篇汪谢丹
  • 1篇胡青刚
  • 1篇郭兴军
  • 1篇李伟

传媒

  • 2篇中华实验外科...
  • 2篇Journa...
  • 1篇中国病理生理...

年份

  • 1篇2009
  • 2篇2008
  • 1篇2007
  • 1篇2005
5 条 记 录,以下是 1-5
排序方式:
Prokaryotic Expression and Biological Activity Analysis of Human Arresten Gene被引量:4
2005年
To express recombinant arresten in Escherichia coli (E.Coli) and investigate its biological activity, prokaryotic expression vector of human arresten gene was constructed by gene engineering. Human arresten gene was amplified from recombinant plasmid pGEMArr by polymerase chain reaction (PCR), and inserted into prokaryotic expression vector pRSET containing T7 promoter. Restriction analysis and DNA sequencing verified that the arresten gene was correctly cloned into the expression vector. The recombinant plasmid pRSETAt was subsequently transformed into E.coli BL21 (DE3), and the target gene was expressed under induction of IPTG. SDS-PAGE analysis revealed that the recombinant protein with a molecular weight of 29 kD (1 kD=0.992 1 ku) amounted to 29 % of the total bacterial proteins. After purification and renaturation, the recombinant protein could significantly suppress the proliferation of human umbilical vein endothelial cells (HUVECs). These results suggested that the expression of a biologically active form of human arresten in the pRSET expression system laid a foundation for further study on the mechanistic insight into arresten action on angiogenesis and the development of powerful anti-cancer drugs.
宋自芳郑启昌李伟熊俊尚丹舒晓刚
关键词:原核表达生物学活性基因表达抗肿瘤药
The Origin of Neointimal Smooth Muscle Cells in Transplant Arteriosclerosis from Recipient Bone-marrow Cells in Rat Aortic Allograft
2007年
In order to investigate the origin of neointimal smooth muscle cells in transplant arterio- sclerosis in rat aortic allograft, sex-mismatched bone marrow transplantation was performed from male Wistar rats to female Wistar rats. Four weeks after transplantation, the aortic transplant model was established by means of micro-surgery in rats. The recipients were divided into 4 groups: female Wistar-female Wistar aortic isografts, female SD-female Wistar aortic allografts, male SD-male Wis- tar aortic allografts, female SD-chimera Wistar aortic allografts. Eight weeks after transplantation, aortic grafts were removed at autopsy and processed for histological evaluation and immunohisto- chemistry. The results indicated that excessive accumulation of α-SMA-positive smooth muscle cells resulted in significant neointima formation and vascular lumen stricture in rat aortic allografts. Neointima assay revealed that the neointimal area and NIA/MA ratio of transplanted artery were sig- nificantly increased in all of aortic allograft groups as compared with those in aortic isograft group (P<0.01). Neointimal smooth muscle cells were harvested from cryostat sections of aortic allograft by microdissection method. The Sry gene-specific PCR was performed, and the result showed that a dis- tinct DNA band of 225 bp emerged in the male-male aortic allograft group and chimera aortic al- lograft group respectively, but not in the female-female aortic allograft group. It was suggested that recipient bone-marrow cells, as the origin of neointimal smooth muscle cells, contributed to the pathological neointimal hyperplasia of aortic allograft and transplant arteriosclerosis.
宋自芳李伟郑启昌尚丹舒晓刚管思明
关键词:AORTICCELLSBONE-MARROWCELLS
阿托伐他汀对大鼠自体移植静脉内膜增生的影响被引量:3
2009年
目的:探讨新型降脂药阿托伐他汀对自体移植静脉内膜增生的影响。方法:将Wistar大鼠颈外静脉移植于腹主动脉,建立大鼠自体静脉移植模型,实验分为3组:假手术组、移植对照组和移植实验组。自术后第1 d起,对移植实验组大鼠经胃管灌注给予阿托伐他汀(5 mg.kg-1.d-1)处理。干预4周后取移植静脉组织标本,制备4μm厚组织切片,行病理组织学观察分析移植静脉内膜增生情况,行免疫组化染色分析新生内膜细胞SMα-actin和PCNA的表达情况。结果:移植对照组和实验组移植静脉内皮下层SMα-actin染色阳性平滑肌细胞大量增生,导致静脉内膜显著增厚,血管管腔明显狭窄。新生内膜定量分析显示移植实验组移植静脉内膜增生受到明显抑制,其新生内膜面积及新生内膜/中膜面积比均显著低于对照组(P<0.01);并且实验组移植静脉新生内膜细胞PCNA标记指数显著低于对照组(P<0.01)。结论:阿托伐他汀通过抑制新生内膜平滑肌细胞的增殖能有效抑制自体移植静脉内膜增生的发生发展,在防治血管重建术后再狭窄方面显示出良好的应用前景。
宋自芳李伟郑启昌尚丹熊俊管思明
关键词:阿托伐他汀血管平滑肌细胞内膜增生自体静脉移植
人arresten基因的真核表达及其对血管平滑肌细胞增殖的影响被引量:1
2008年
目的真核表达人arresten蛋白,并观察其对血管平滑肌细胞体外增殖的影响。方法用脂质体介导,将含有人arresten基因的重组质粒pSecTag2-AT转染COS-7细胞;应用逆转录-聚合酶链反应(RT—PCR)检测转染细胞目的基因mRNA表达;收集浓缩转染48h细胞上清液,Western blot检测目的蛋白的表达。离体培养大鼠血管平滑肌细胞,用CCK-8法检测转染细胞上清液对平滑肌细胞体外增殖的影响。结果重组质粒pSecTag2-AT转染的COS-7细胞有目的基因mRNA的表达;转染细胞上清液中有arresten蛋白的表达。细胞体外增殖分析显示转染细胞上清液可显著抑制血管平滑肌细胞的体外增殖(F=40.154,P〈0.01)。结论真核表达的人arresten蛋白能有效抑制血管平滑肌细胞的体外增殖,为日后开展抑制血管新生内膜增生的基因治疗奠定了基础。
尚丹郑启昌宋自芳舒晓刚汪谢丹郭兴军
关键词:血管平滑肌细胞细胞增殖基因表达
重组arresten蛋白对自体移植静脉内膜增生的抑制作用被引量:1
2008年
目的观察原核表达人arresten重组蛋白对自体移植静脉内膜增生的抑制作用。方法用pRSET原核表达系统表达并纯化人arresten重组蛋白。将Wistar大鼠颈外静脉移植于腹主动脉,建立大鼠自体静脉移植模型,实验分3组:假手术组、移植对照组和移植实验组。自术后第3天起,皮下注射给予arresten重组蛋白(每日4mg/kg体重)处理。4周后取移植静脉组织标本,进行病理组织学观察与免疫组织化学染色分析。结果移植组移植静脉均呈现典型的内膜增生、肥厚,导致血管管腔狭窄;新生内膜主要有过度增殖的α-SMA染色阳性平滑肌细胞组成。移植实验组移植静脉内膜增生受到明显抑制,新生内膜面积(0.12±0.07)mm^2。及新生内膜/中膜面积比(0.373±0.085)均显著低于对照组[(0.38±0.11)mm^2。,1.621±0.086,P〈0.01];并且实验组移植静脉新生内膜细胞PCNA标记指数显著低于对照组[(15.62±3.97)%比(56.36±3.49)%,P〈0.01]。结论重组arresten蛋白通过抑制新生内膜平滑肌细胞的增殖能有效抑制自体移植静脉内膜增生的发生发展,在防治血管重建术后再狭窄方面显示出良好的应用前景。
宋自芳郑启昌尚丹舒晓刚熊俊胡青刚
关键词:ARRESTEN重组蛋白内膜增生自体静脉移植
共1页<1>
聚类工具0